The Effect of Pulmonary Rehabilitation on Improving the Quality of Life in Patients with Chronic Obstructive Pulmonary Disease

Investigating the improvement in activity of patients with chronic obstructive pulmonary disease following pulmonary rehabilitation based on mMRC and 6mwt

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191104045328N43

Enrollment

Registered

2025-10-08

Start date

2025-10-17

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease. Chronic obstructive pulmonary disease, unspecified

Interventions

Intervention group: Patients will undergo a comprehensive pulmonary rehabilitation program supervised by a physiotherapist for a duration of eight weeks, with a frequency of two to three sessions per

Eligibility

Sex/Gender

All

Age

20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Confirmed diagnosis of Chronic Obstructive Pulmonary Disease based on spirometry. Clinically stable condition (no hospitalization or exacerbation in the last 4 weeks). Ability to understand, cooperate, perform tests, and attend sessions regularly.

Exclusion criteria

Exclusion criteria: Unstable or severe cardiovascular disease (e.g., unstable angina, severe heart failure). Severe mobility limitations (orthopedic or neurological) preventing exercise. Concurrent participation in other rehabilitation programs or unwillingness to follow the protocol.

Design outcomes

Primary

Measure	Time frame
Six-minute walk test. Timepoint: Before and after the intervention. Method of measurement: Distance covered in the six-minute walk test.;Level of Dyspnea. Timepoint: Before and after the intervention. Method of measurement: Modified Medical Research Council Questionnaire.;Disease’s impact on quality of life. Timepoint: Before and after the intervention. Method of measurement: Chronic Obstructive Pulmonary Disease Assessment Test.;Forced Expiratory Volume in 1 second (FEV1). Timepoint: Before and after the intervention. Method of measurement: Spirometry.;Forced Vital Capacity (FVC). Timepoint: Before and after the intervention. Method of measurement: Spirometry.;FEV1/FVC index. Timepoint: Before and after the intervention. Method of measurement: Spirometry.	—

Measure

Time frame

Six-minute walk test. Timepoint: Before and after the intervention. Method of measurement: Distance covered in the six-minute walk test.;Level of Dyspnea. Timepoint: Before and after the intervention. Method of measurement: Modified Medical Research Council Questionnaire.;Disease’s impact on quality of life. Timepoint: Before and after the intervention. Method of measurement: Chronic Obstructive Pulmonary Disease Assessment Test.;Forced Expiratory Volume in 1 second (FEV1). Timepoint: Before and after the intervention. Method of measurement: Spirometry.;Forced Vital Capacity (FVC). Timepoint: Before and after the intervention. Method of measurement: Spirometry.;FEV1/FVC index. Timepoint: Before and after the intervention. Method of measurement: Spirometry.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Behnaz Movahedi

Karaj University of Medical Sciences

behmov@yahoo.com+98 26 3455 2001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026